ResearcherLanzhou UniversityActive in the last 2 years

Wenke Qin

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma:… Co-author DOI 10.3389/fimmu.2025.1654425 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jubao Niu · 1 shared paper, 2025 · strength 0.23
- Paper Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or meta… DOI 10.3389/fimmu.2025.1654425 ↗
Kongyuan Wei · 1 shared paper, 2025 · strength 0.23
- Paper Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or meta… DOI 10.3389/fimmu.2025.1654425 ↗
Hui Zhang · 1 shared paper, 2025 · strength 0.23
- Paper Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or meta… DOI 10.3389/fimmu.2025.1654425 ↗
Xin Li · 1 shared paper, 2025 · strength 0.23
- Paper Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or meta… DOI 10.3389/fimmu.2025.1654425 ↗
Yan Zhang · 1 shared paper, 2025 · strength 0.23
- Paper Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or meta… DOI 10.3389/fimmu.2025.1654425 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.